Insights into significant pathways and gene interaction networks underlying breast cancer cell line MCF-7 treated with 17β-Estradiol (E2)

Gene

Volumn 533, Issue 1, 2014, Pages 346-355

  Huan, Jinliang ^a   Wang, Lishan ^b   Xing, Li ^a   Qin, Xianju ^a   Feng, Lingbin ^a   Pan, Xiaofeng ^a   Zhu, Ling ^a  

^a The Eighth People's Hospital Of Shanghai   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

17 Estradiol (E2); Breast cancer; Gene; MCF 7

Indexed keywords

CELL ADHESION MOLECULE; CHEMOKINE; CYTOKINE RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; ESTRADIOL; ESTROGEN RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; TRANSCRIPTION FACTOR; WNT PROTEIN;

ACTIN FILAMENT; ARTICLE; BREAST CANCER; CALCIUM SIGNALING; CANCER CELL CULTURE; CELL PROLIFERATION; DNA METHYLATION; FOCAL ADHESION; GENE EXPRESSION PROFILING; GENE INTERACTION; GENOME ANALYSIS; HUMAN; HUMAN CELL; METABOLISM; MICROARRAY ANALYSIS; NERVE FIBER; PHENOTYPE; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION;

17Β-ESTRADIOL (E2); BREAST CANCER; CAMS; CELL ADHESION MOLECULES; DATABASE FOR ANNOTATION, VISUALIZATION, AND INTEGRATED DISCOVERY; DAVID; DEGS; DIFFERENTIALLY EXPRESSED GENES; EASE; ER; ERES; ESTROGEN RECEPTOR; ESTROGEN RESPONSIVE ELEMENTS; EXPRESSION ANALYSIS SYSTEMATIC EXPLORE; FA; FOCAL ADHESION; GENE; GENE EXPRESSION OMNIBUS; GEO; IGSF; IGSFCAMS; IMMUNOGLOBULIN SUPERFAMILY; IMMUNOGLOBULIN SUPERFAMILY CELL ADHESION MOLECULES; KEGG; KYOTO ENCYCLOPEDIA OF GENES AND GENOMES; MCAM; MCF-7; MELANOMA CELL ADHESION MOLECULE;

BREAST NEOPLASMS; ESTRADIOL; FEMALE; GENE REGULATORY NETWORKS; HUMANS; MCF-7 CELLS;

EID: 84887241795     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2013.08.027     Document Type: Article

References (59)

1. Adam L., Vadlamudi R., Kondapaka S.B., Chernoff J., Mendelsohn J., Kumar R. Heregulin regulates cytoskeletal reorganization and cell migration through the p21-activated kinase-1 via phosphatidylinositol-3 kinase. J. Biol. Chem. 1998, 273:28238-28246.
2. Baldwin J.M. The probable arrangement of the helices in G protein-coupled receptors. EMBO J. 1993, 12:1693.
3. Barone I., Brusco L., Fuqua S.A. Estrogen receptor mutations and changes in downstream gene expression and signaling. Clin. Cancer Res. 2010, 16:2702-2708.
4. Benjamini Y.a.Y.H. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. 1995, 289-300.
5. Binai N.A., Carra G., Lower J., Lower R., Wessler S. Differential gene expression in ERalpha-positive and ERalpha-negative breast cancer cells upon leptin stimulation. Endocrine 2013, (in press).
6. Chan H.-S., et al. Serine protease PRSS23 is upregulated by estrogen receptor α and associated with proliferation of breast cancer cells. PLoS One 2012, 7:e30397.
7. Chatr-aryamontri A., et al. MINT: the Molecular INTeraction database. Nucleic Acids Res. 2007, 35:D572-D574.
8. Chen J., et al. Calycosin stimulates proliferation of estrogen receptor-positive human breast cancer cells through downregulation of Bax gene expression and upregulation of Bcl-2 gene expression at low concentrations. J. Parenter. Enter. 2011, 35:763-769.
9. Colombo P.E., Milanezi F., Weigelt B., Reis-Filho J.S. Microarrays in the 2010s: the contribution of microarray-based gene expression profiling to breast cancer classification, prognostication and prediction. Breast Cancer Res. 2011, 13:212.
10. Cui G., Chen Y., Huang D.S., Han K. An algorithm for finding functional modules and protein complexes in protein-protein interaction networks. J. Biomed. Biotechnol. 2008, 860270.
11. Dahlman-Wright K., et al. International Union of Pharmacology. LXIV. Estrogen receptors. Pharmacol. Rev. 2006, 58:773-781.
12. Frasor J., Danes J.M., Komm B., Chang K.C., Lyttle C.R., Katzenellenbogen B.S. Profiling of estrogen up-and down-regulated gene expression in human breast cancer cells: insights into gene networks and pathways underlying estrogenic control of proliferation and cell phenotype. Endocrinology 2003, 144:4562-4574.
13. Fu X.-D., et al. Extra-nuclear signaling of progesterone receptor to breast cancer cell movement and invasion through the actin cytoskeleton. PLoS One 2008, 3:e2790.
14. Heinzelmann-Schwarz V.A., et al. Overexpression of the cell adhesion molecules DDR1, Claudin 3, and Ep-CAM in metaplastic ovarian epithelium and ovarian cancer. Clin. Cancer Res. 2004, 10:4427-4436.
15. Hinohara K., et al. ErbB receptor tyrosine kinase/NF-kappaB signaling controls mammosphere formation in human breast cancer. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:6584-6589.
16. Huang da W., et al. The DAVID Gene Functional Classification Tool: a novel biological module-centric algorithm to functionally analyze large gene lists. Genome Biol. 2007, 8:R183.
17. Ifon E.T., et al. U94 alters FN1 and ANGPTL4 gene expression and inhibits tumorigenesis of prostate cancer cell line PC3. Cancer Cell Int. 2005, 5:19.
18. Irizarry R.A., et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 2003, 4:249-264.
19. Jagannathan V., Robinson-Rechavi M. Meta-analysis of estrogen response in MCF-7 distinguishes early target genes involved in signaling and cell proliferation from later target genes involved in cell cycle and DNA repair. BMC Syst. Biol. 2011, 5:138.
20. Jarzab B., et al. Gene expression profile of papillary thyroid cancer: sources of variability and diagnostic implications. Cancer Res. 2005, 65:1587-1597.
21. Jemal A., Bray F., Center M.M., Ferlay J., Ward E., Forman D. Global cancer statistics. CA Cancer J. Clin. 2002, 61:69-90.
22. Jiang Y., et al. Discovery of differentially expressed genes in human breast cancer using subtracted cDNA libraries and cDNA microarrays. Oncogene 2002, 21:2270-2282.
23. Jing J., Tarbutton E., Wilson G., Prekeris R. Rab11-FIP3 is a Rab11-binding protein that regulates breast cancer cell motility by modulating the actin cytoskeleton. Eur. J. Cell Biol. 2009, 88:325-341.
24. Jones S., et al. Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science 2008, 321:1801-1806.
25. Kalaitzidis D., Gilmore T.D. Transcription factor cross-talk: the estrogen receptor and NF-κB. Trends Endocrinol. Metab. 2005, 16:46-52.
26. Kato S. Estrogen receptor-mediated cross-talk with growth factor signaling pathways. Breast Cancer 2001, 8:3-9.
27. Lin C.Y., et al. Whole-genome cartography of estrogen receptor alpha binding sites. PLoS Genet. 2007, 3:e87.
28. Lobenhofer E.K., Bennett L., Cable P.L., Li L., Bushel P.R., Afshari C.A. Regulation of DNA replication fork genes by 17beta-estradiol. Mol. Endocrinol. 2002, 16:1215-1229.
29. Lyng M.B., et al. Gene expression signatures that predict outcome of tamoxifen-treated estrogen receptor-positive, high-risk, primary breast cancer patients: a DBCG study. PLoS One 2013, 8:e54078.
30. Mishra G.R., et al. Human protein reference database-2006 update. Nucleic Acids Res. 2006, 34:D411-D414.
31. Miyakoshi K., Murphy M.J., Yeoman R.R., Mitra S., Dubay C.J., Hennebold J.D. The identification of novel ovarian proteases through the use of genomic and bioinformatic methodologies. Biol. Reprod. 2006, 75:823-835.
32. Mukherjee D., Zhao J. The role of chemokine receptor CXCR4 in breast cancer metastasis. Am. J. Cancer Res. 2013, 3:46-57.
33. Nasser M.W., et al. Crosstalk between chemokine receptor CXCR4 and cannabinoid receptor CB2 in modulating breast cancer growth and invasion. PLoS One 2011, 6:e23901.
34. Nepusz T., Yu H., Paccanaro A. Detecting overlapping protein complexes in protein-protein interaction networks. Nat. Methods 2012, 9:471-472.
35. Neumaier M., Paululat S., Chan A., Matthaes P., Wagener C. Biliary glycoprotein, a potential human cell adhesion molecule, is down-regulated in colorectal carcinomas. Proc. Natl. Acad. Sci. 1993, 90:10744-10748.
36. Nilsson S., Gustafsson J.A. Estrogen receptor action. Crit. Rev. Eukaryot. Gene Expr. 2002, 12:237-257.
37. O'Neill G.M. Scared stiff: Stabilizing the actin cytoskeleton to stop invading cancer cells in their tracks. Bioarchitecture 2011, 1:29-31.
38. Platet N., Cathiard A.M., Gleizes M., Garcia M. Estrogens and their receptors in breast cancer progression: a dual role in cancer proliferation and invasion. Crit. Rev. Oncol. Hematol. 2004, 51:55-67.
39. Sakwe A.M., Koumangoye R., Guillory B., Ochieng J. Annexin A6 contributes to the invasiveness of breast carcinoma cells by influencing the organization and localization of functional focal adhesions. Exp. Cell Res. 2011, 317:823-837.
40. Sharma S., Kelly T.K., Jones P.A. Epigenetics in cancer. Carcinogenesis 2008, 31:27-36.
41. Sheen-Chen S.M., et al. An evaluation of focal adhesion kinase in breast cancer by tissue microarrays. Anticancer Res. 2013, 33:1169-1173.
42. Smoot M.E., Ono K., Ruscheinski J., Wang P.L., Ideker T. Cytoscape 2.8: new features for data integration and network visualization. Bioinformatics 2011, 27:431-432.
43. Smyth G.K. Linear models and empirical Bayes methods for assessing differential expression in microarray experiments. Stat. Appl. Genet. Mol. Biol. 2004, 3. (Article3).
44. Sommer S., Fuqua S.A. Estrogen receptor and breast cancer. Semin. Cancer Biol. 2001, 11:339-352.
45. Sorlie T., et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:10869-10874.
46. Stark C., et al. The BioGRID interaction database: 2011 update. Nucleic Acids Res. 2011, 39:D698-D704.
47. Stender J.D., Stossi F., Funk C.C., Charn T.H., Barnett D.H., Katzenellenbogen B.S. The estrogen-regulated transcription factor PITX1 coordinates gene-specific regulation by estrogen receptor-alpha in breast cancer cells. Mol. Endocrinol. 2011, 25:1699-1709.
48. Team R.D.C. R: A Language and Environment for Statistical Computing 2008, R Foundation for Statistical Computing.
49. Van der Auwera I., et al. Array-based DNA methylation profiling for breast cancer subtype discrimination. PLoS One 2010, 5:e12616.
50. Van Laere S.J., et al. Uncovering the molecular secrets of Inflammatory Breast Cancer biology: an integrated analysis of three distinct Affymetrix gene expression data sets. Clin. Cancer Res 2013, 19:4685-4696.
51. van 't Veer L.J., et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature 2002, 415:530-536.
52. Wai Wong C., Dye D.E., Coombe D.R. The role of immunoglobulin superfamily cell adhesion molecules in cancer metastasis. Int. J. Cell Biol. 2012, 340296.
53. Wai Wong C., Dye D.E., Coombe D.R. The role of immunoglobulin superfamily cell adhesion molecules in cancer metastasis. Int. J. Cell Biol. 2012, 2012:340296.
54. Worzfeld T., Swiercz J.M., Looso M., Straub B.K., Sivaraj K.K., Offermanns S. ErbB-2 signals through Plexin-B1 to promote breast cancer metastasis. J. Clin. Invest. 2012, 122:1296-1305.
55. Xu Y., et al. Filamin A regulates focal adhesion disassembly and suppresses breast cancer cell migration and invasion. J. Exp. Med. 2010, 207:2421-2437.
56. Yamaguchi H., Condeelis J. Regulation of the actin cytoskeleton in cancer cell migration and invasion. Biochim. Biophys. Acta (BBA) - Mol. Cell Res. 2007, 1773:642-652.
57. Yamazaki D., Kurisu S., Takenawa T. Regulation of cancer cell motility through actin reorganization. Cancer sci 2005, 96:379-386.
58. Yasuda H., Itoh F. Role of Bile Acids in Carcinogenesis of Gastrointestinal Tract, Cell Signaling & Molecular Targets in Cancer 2012, 109-128. Springer.
59. Zajchowski D.A., et al. Identification of gene expression profiles that predict the aggressive behavior of breast cancer cells. Cancer Res. 2001, 61:5168-5178.